Press Release | Fri Jun 7, 2013 8:30am EDT

Esperion Therapeutics Announces Positive Top-Line Results from Phase 2 Clinical Study of Novel Oral Therapy in Patients with Hypercholesterolemia and a History of Statin Intolerance

* Reuters is not responsible for the content in this press release.